News

Willis Towers Watson (WTW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shares of Willis Towers Watson PLC WTW rallied 1.61% to $321.74 Friday, on what proved to be an all-around great trading ...
Investors looking for a place to ride out a possible recession might want to consider the stocks of insurance brokers. These ...
The US insurer Willis Towers Watson is an alternative to defensive US stocks from the food industry. The business is ...
Barclays analyst Alex Scott maintained a Sell rating on Willis Towers Watson (WTW – Research Report) today and set a price target of $316.00.
Willis Towers Watson earns the No. 9 rank among its peers in the Insurance-Brokers industry group. Kingstone, Ryan Specialty ...
Insurance broker giant Marsh McLennan's first-quarter profit exceeded analysts' expectation on Thursday, thanks to strong performance in its risk and insurance services business. WHY IT IS IMPORTANT ...
London-U.K.-based Willis Towers Watson Public Limited Company (WTW) is a leading global advisory, broking and solutions company. Its solutions include risk management, benefits optimization and ...
Almost half (46%) of multinational organisations said they are prioritising the use of employee-facing technology to support ...
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments: Health, Wealth & Career and Risk & Broking.
In a report released on April 11, Andrew Andersen from Jefferies maintained a Sell rating on Lemonade (LMND – Research Report), with a price target of $23.00. The company’s sh ...